UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reduction in the Risk of Clinical Fractures After a Single Dose of Zoledronic Acid 5 Milligrams

The journal of clinical endocrinology and metabolism, 2013-02, Vol.98 (2), p.557-563

2013

Volltextzugriff (PDF)

Association between timing of zoledronic acid infusion and hip fracture healing

Osteoporosis international, 2011-08, Vol.22 (8), p.2329-2336

2011

Volltextzugriff (PDF)

Hip and other osteoporotic fractures increase the risk of subsequent fractures in nursing home residents

Osteoporosis international, 2008-08, Vol.19 (8), p.1225-1233

2008

Volltextzugriff (PDF)

Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial

Osteoporosis international, 2014, Vol.25 (1), p.77-83

2014

Volltextzugriff (PDF)

Zoledronic acid results in better health-related quality of life following hip fracture: the HORIZON–Recurrent Fracture Trial

Osteoporosis international, 2011-09, Vol.22 (9), p.2539-2549

2011

Volltextzugriff (PDF)

Prevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fracture

Osteoporosis international, 2007-04, Vol.18 (4), p.553-559

2007

Volltextzugriff (PDF)

Association of prior treatment with nitrogen-containing bisphosphonates on outcomes of COVID-19 positive patients

Osteoporosis international, 2024, Vol.35 (1), p.181-187

2024

Volltextzugriff (PDF)

A Clinical Approach to Diagnosis and Management of Paget's Disease of Bone

Journal of bone and mineral research, 2001-08, Vol.16 (8), p.1379-1387

2001

Volltextzugriff (PDF)

The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies

Osteoporosis international, 2003-11, Vol.14 (11), p.879-883

2003

Volltextzugriff (PDF)

Zoledronic acid reduces the rate of clinical fractures after surgical repair of a hip fracture regardless of the Pretreatment bone mineral density

Osteoporosis international, 2021-06, Vol.32 (6), p.1217-1219

2021

Volltextzugriff (PDF)

Osteoporosis and Depression: Shedding More Light Upon a Complex Relationship

Journal of the American Geriatrics Society (JAGS), 2001-06, Vol.49 (6), p.827-828

Lyles, K W

2001

Volltextzugriff (PDF)

Timed loaded standing : A measure of combined trunk and arm endurance suitable for people with vertebral osteoporosis

Osteoporosis international, 2000-11, Vol.11 (11), p.914-922

2000

Volltextzugriff (PDF)

Paget's disease of bone and quality of life

Journal of bone and mineral research, 1996-12, Vol.11 (12), p.1897-1904

1996

Volltextzugriff (PDF)

Group Treatment Improves Trunk Strength and Psychological Status in Older Women with Vertebral Fractures: Results of a Randomized, Clinical Trial

Journal of the American Geriatrics Society (JAGS), 2004-09, Vol.52 (9), p.1471-1478

2004

Volltextzugriff (PDF)

Management of Patients with Vertebral Compression Fractures

Pharmacotherapy, 1999-01, Vol.19 (1P2), p.21S-24S

Lyles, Kenneth W.

1999

Volltextzugriff (PDF)

MANAGING PATIENTS WITH COMPLICATIONS OF OSTEOPOROSIS

Endocrinology and metabolism clinics of North America, 1998-06, Vol.27 (2), p.485-496

1998

Volltextzugriff (PDF)

Risk factors for hip fracture in skilled nursing facilities: Who should be evaluated?

Osteoporosis international, 2003-07, Vol.14 (6), p.484-489

2003

Volltextzugriff (PDF)

Antiresorptive effect of a single infusion of microgram quantities of zoledronate in Paget's disease of bone

Calcified tissue international, 1997-05, Vol.60 (5), p.415-418

1997

Volltextzugriff (PDF)

Association of osteoporotic vertebral compression fractures with impaired functional status

The American journal of medicine, 1993-06, Vol.94 (6), p.595-601

1993

Volltextzugriff (PDF)

Factors associated with self‐rated health in patients with paget's disease of bone

Journal of bone and mineral research, 1999-10, Vol.14 (S2), p.99-102

1999

Volltextzugriff (PDF)

Peyronie's Disease Is Associated with Paget's Disease of Bone

Journal of bone and mineral research, 1997-06, Vol.12 (6), p.929-934

1997

Volltextzugriff (PDF)

Bisphosphonate use is associated with reduced risk of myocardial infarction in patients with rheumatoid arthritis

Journal of bone and mineral research, 2013-05, Vol.28 (5), p.984-991

2013

Volltextzugriff (PDF)

Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture

The New England journal of medicine, 2007-11, Vol.357 (18), p.1799-1809

2007

Volltextzugriff (PDF)

Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia: induction and maintenance with phosphorus and calcitriol

The Journal of clinical investigation, 1985-06, Vol.75 (6), p.1858-1868

1985

Volltextzugriff (PDF)

Antifracture Efficacy and Reduction of Mortality in Relation to Timing of the First Dose of Zoledronic Acid After Hip Fracture

Journal of bone and mineral research, 2009-07, Vol.24 (7), p.1308-1313

2009

Volltextzugriff (PDF)

1 – 25 von 233

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(207)
Mit Volltextzugriff
(173)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(231)

Erscheinungsjahr

n.n

Thema

Science & Technology
(169)
Life Sciences & Biomedicine
(154)
Humans
(148)
Female
(94)
Male
(90)
Aged
(76)
Biological And Medical Sciences
(73)
Medical Sciences
(64)
Middle Aged
(47)
Adult
(39)
Endocrinology & Metabolism
(39)
Aged, 80 And Over
(33)
General & Internal Medicine
(30)
Medicine, General & Internal
(28)
Osteoporosis
(26)
Risk Factors
(24)
Fractures
(21)
Animals
(20)
Diphosphonates - Therapeutic Use
(20)
Diseases Of The Osteoarticular System
(19)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Reduction in the Risk of Clinical Fractures After a Single Dose of Zoledronic Acid 5 Milligrams

Association between timing of zoledronic acid infusion and hip fracture healing

Hip and other osteoporotic fractures increase the risk of subsequent fractures in nursing home residents

Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial

Zoledronic acid results in better health-related quality of life following hip fracture: the HORIZON–Recurrent Fracture Trial

Prevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fracture

Association of prior treatment with nitrogen-containing bisphosphonates on outcomes of COVID-19 positive patients

A Clinical Approach to Diagnosis and Management of Paget's Disease of Bone

The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies

Zoledronic acid reduces the rate of clinical fractures after surgical repair of a hip fracture regardless of the Pretreatment bone mineral density

Osteoporosis and Depression: Shedding More Light Upon a Complex Relationship

Timed loaded standing : A measure of combined trunk and arm endurance suitable for people with vertebral osteoporosis

Paget's disease of bone and quality of life

Group Treatment Improves Trunk Strength and Psychological Status in Older Women with Vertebral Fractures: Results of a Randomized, Clinical Trial

Management of Patients with Vertebral Compression Fractures

MANAGING PATIENTS WITH COMPLICATIONS OF OSTEOPOROSIS

Risk factors for hip fracture in skilled nursing facilities: Who should be evaluated?

Antiresorptive effect of a single infusion of microgram quantities of zoledronate in Paget's disease of bone

Association of osteoporotic vertebral compression fractures with impaired functional status

Factors associated with self‐rated health in patients with paget's disease of bone

Peyronie's Disease Is Associated with Paget's Disease of Bone

Bisphosphonate use is associated with reduced risk of myocardial infarction in patients with rheumatoid arthritis

Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture

Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia: induction and maintenance with phosphorus and calcitriol

Antifracture Efficacy and Reduction of Mortality in Relation to Timing of the First Dose of Zoledronic Acid After Hip Fracture

Suchergebnisse filtern